Efficacy of Sirolimus Treatment in PEComa–10 Years of Practice Perspective

Efficacy of Sirolimus Treatment in PEComa–10 Years of Practice Perspective

Perivascular epithelioid cell tumors (PEComa) represent a family of rare mesenchymal tumors resultant from deregulation in mTOR pathway activity. The aim of this study is to evaluate the long-term efficacy of targeted PEComa treatment. We reviewed all consecutive patients with PEComa who started sys...

Full description

Bibliographic Details
Main Authors: Tomasz Świtaj, Aleksandra Sobiborowicz, Paweł Teterycz, Anna Klimczak, Donata Makuła, Michał Wągrodzki, Anna Szumera-Ciećkiewicz, Piotr Rutkowski, Anna M. Czarnecka
Format: Article
Language:English
Published: MDPI AG 2021-08-01
Series:Journal of Clinical Medicine
Subjects:
perivascular epithelioid cell tumor
PEComa
lymphangioleiomyomatosis
sarcoma
sirolimus
mTOR inhibitors
Online Access:https://www.mdpi.com/2077-0383/10/16/3705

Internet

https://www.mdpi.com/2077-0383/10/16/3705

Similar Items